Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of platelet-rich plasma, extracorporeal shockwave therapy, and usual care for work-related epicondylitis
2018-002650-67Phase 3Active
- Sponsor
- Ibermutuamur
- Start
- Aug 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in Lateral Epicondylitis (LET) (3 arms), sponsored by Ibermutuamur. Primary endpoints: Pain visual analog scale and Disabilities of the Arm, Shoulder and Hand score. Started Aug 2018; status: active.
02
Drugs
platelet-rich plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2018-002650-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002650-67.